Xponance Inc. Acquires 1,177 Shares of The Chemours Company (NYSE:CC)

Xponance Inc. lifted its stake in The Chemours Company (NYSE:CC) by 6.7% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 18,648 shares of the specialty chemicals company’s stock after purchasing an additional 1,177 shares during the period. Xponance Inc.’s holdings in Chemours were worth $315,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also made changes to their positions in the stock. GAMMA Investing LLC grew its holdings in Chemours by 99.7% during the fourth quarter. GAMMA Investing LLC now owns 1,532 shares of the specialty chemicals company’s stock valued at $26,000 after purchasing an additional 765 shares during the period. Truvestments Capital LLC acquired a new position in shares of Chemours in the 3rd quarter valued at $35,000. Brooklyn Investment Group bought a new stake in shares of Chemours in the 3rd quarter valued at $37,000. KBC Group NV increased its position in shares of Chemours by 38.2% in the 4th quarter. KBC Group NV now owns 6,176 shares of the specialty chemicals company’s stock valued at $104,000 after buying an additional 1,708 shares in the last quarter. Finally, EMC Capital Management raised its stake in Chemours by 74.6% during the 4th quarter. EMC Capital Management now owns 9,534 shares of the specialty chemicals company’s stock worth $161,000 after buying an additional 4,073 shares during the period. 76.26% of the stock is currently owned by institutional investors.

Chemours Price Performance

NYSE:CC opened at $14.29 on Friday. The stock has a market capitalization of $2.14 billion, a PE ratio of 25.07 and a beta of 2.00. The Chemours Company has a 1-year low of $13.09 and a 1-year high of $29.21. The firm has a fifty day simple moving average of $16.52 and a 200 day simple moving average of $18.21. The company has a current ratio of 1.68, a quick ratio of 0.92 and a debt-to-equity ratio of 6.70.

Chemours (NYSE:CC) last announced its quarterly earnings data on Tuesday, February 18th. The specialty chemicals company reported $0.11 EPS for the quarter, beating analysts’ consensus estimates of $0.10 by $0.01. Chemours had a net margin of 1.51% and a return on equity of 26.54%. The company had revenue of $1.36 billion during the quarter, compared to the consensus estimate of $1.37 billion. On average, research analysts expect that The Chemours Company will post 2.03 EPS for the current fiscal year.

Chemours Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, March 14th. Stockholders of record on Friday, February 28th were given a $0.25 dividend. The ex-dividend date of this dividend was Friday, February 28th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 7.00%. Chemours’s payout ratio is 175.44%.

Analyst Ratings Changes

A number of research firms have issued reports on CC. The Goldman Sachs Group decreased their target price on Chemours from $24.00 to $21.00 and set a “neutral” rating for the company in a research note on Tuesday, January 7th. Mizuho raised Chemours from a “neutral” rating to an “outperform” rating and set a $19.00 target price for the company in a research note on Thursday. BMO Capital Markets cut their price target on shares of Chemours from $34.00 to $27.00 and set an “outperform” rating on the stock in a research note on Wednesday, February 19th. Morgan Stanley reduced their price target on shares of Chemours from $25.00 to $22.00 and set an “equal weight” rating for the company in a report on Monday, January 13th. Finally, Royal Bank of Canada restated an “outperform” rating and set a $25.00 price objective on shares of Chemours in a report on Thursday, December 12th. Four investment analysts have rated the stock with a hold rating and five have given a buy rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $22.89.

About Chemours

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.